- Home
- Equipment
- north america
- biomarker testing
Show results for
Refine by
Biomarker Testing Equipment Supplied In North America
13 equipment items found
Manufactured by:Polymedco, LLC based inCortlandt Manor, NEW YORK (USA)
The PATHFAST Analyzer is designed to enhance cardiac care in emergency department settings by providing high-sensitivity cardiac troponin (hs-cTn) and NT-proBNP testing capabilities. This compact, benchtop device delivers rapid, lab-quality results within 17 minutes from whole blood samples, utilizing chemiluminescence and Magtration® technology. The system's flexibility allows simultaneous ...
Manufactured by:Bionote based inBig Lake, MINNESOTA (USA)
The first and only rapid, in-clinic canine cardiac biomarker test, Vcheck's cNT-proBNP test allows for identification of this marker to assess NT-proBNP concentration increases secondary to excessive stretching of heart muscle cells, allowing this marker to be used to assess the severity of underlying heart ...
Manufactured by:Biocept based inSan Diego, CALIFORNIA (USA)
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
Manufactured by:Biocept based inSan Diego, CALIFORNIA (USA)
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
Manufactured by:Bionote based inBig Lake, MINNESOTA (USA)
Bionote's Vcheck V200 analyzer for veterinary fluorescence immunoassay can help point-of-care testing for various biomarkers, in-clinic at smaller practices and clinics. It helps check quantitative measurement of biomarker levels in serum, plasma and whole blood delivered for analysis via one of Vcheck’s 12 biomarker ...
by:Progentec Diagnostics, Inc. based inOklahoma City, OKLAHOMA (USA)
A BIOMARKER BASED TEST TO MEASURE CURRENT DISEASE ACTIVITY. THE AISLE DX DISEASE ACTIVITY TEST SUPPORTS CLINICIANS IN THE MEASUREMENT OF LUPUS (SLE) AND THE ASSESSMENT OF TREATMENTS. BLOOD PLASMA BASED ...
Manufactured by:Phoresa, Inc. based inSeattle, WASHINGTON (USA)
Our technology uses an electric field and custom assay chemistry to concentrate target biomarkers at the capture test line. The highly concentrated sample results in lower detection limits and higher clinical sensitivity to aid in patient diagnosis for infectious diseases. Phoresa specializes in the design and development of high sensitivity immunoassays ...
Manufactured by:Bionote based inBig Lake, MINNESOTA (USA)
Bionote's Vcheck V2400 analyzer for veterinary fluorescence immunoassay can help point-of-care testing for various biomarkers, in-house at larger patient care facilities. It provides quantitative measurement of biomarker concentration in serum, plasma and whole blood delivered for analysis via Vcheck’s test strips for 12 ...
by:North American Science Associates Inc.(NAMSA ) based inNorthwood, OHIO (USA)
We use our human skin model to test lead formulations and screen them against a variety of parameters in human skin to ensure clinical success. We perform antimicrobial efficacy testing, biomarker assessments, and host cell toxicity on wounded or unwounded skin. ...
Manufactured by:Novodiax, Inc. based inHayward, CALIFORNIA (USA)
Cluster of Differentiation 20 (CD20) is a polymerized horseradish peroxidase (pHRP)-labeled anti-CD20 (R272) rabbit monoclonal antibody intended for laboratory use using frozen or formalin-fixed-paraffin-embedded tissues. CD20 also known as B-lymphocyte antigen, is a membrane polypeptide protein that is present in a majority of B-cells in peripheral blood and lymphoid ...
Manufactured by:Kura Oncology, Inc. based inSan Diego, CALIFORNIA (USA)
With the advent of precision medicines that can target unique molecular or genetic features of a patient’s tumor, the field of oncology has a host of alternatives to one-size-fits-all treatments. This is a major advance over traditional chemotherapy, which can be as potent against healthy tissue as it is against cancer. Using tumor genomic profiling and biomarker strategies, physicians can ...
by:Glycotest, Inc based inMerion, PENNSYLVANIA (USA)
Glycotest blood tests are being developed to provide information on the likelihood of serious liver disease like cancer or fibrosis-cirrhosis by employing technology designed to measure two kinds of disease signals: The amount of the monosaccharide fucose that appears abnormally on certain serum glycoproteins—to indicate likelihood of disease. The pattern of glycoproteins that is abnormally ...
Manufactured by:Nanostics Inc. based inEdmonton, ALBERTA (CANADA)
Our core technology ClarityDX® can: Identify biomarkers expressed by diseased cells/tissues. Indicate if treatment is needed. Predict treatment response and resistance. Stratify disease stage. Identify disease ...